Amazon Web Services (AWS) announced that it is collaborating with EvolutionaryScale, an AI company focused on biology, to give scientists and researchers access to the startup's ESM3 language models via AWS to advance drug discovery by allowing for the creation of new proteins.
Yesterday, EvolutionaryScale, founded by former researchers at Meta’s AI research lab, announced it secured $142 million...
